SARS-CoV-2 IgG seroprevalence surveys in blood donors before the vaccination campaign, France 2020-2021-Reference-Cited by-同舟云学术

SARS-CoV-2 IgG seroprevalence surveys in blood donors before the vaccination campaign, France 2020-2021

Published:2023-04 Issue:4 Volume:26 Page:106222
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Gallian Pierre,Hozé Nathanaël,Brisbarre Nadège,Saba Villarroel Paola Mariela,Nurtop Elif^ORCID,Isnard Christine,Pastorino Boris,Richard Pascale,Morel Pascal,Cauchemez Simon,de Lamballerie Xavier

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference30 articles.

1. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship;Mizumoto;Euro Surveill.,2020

2. Reinfection with new variants of SARS-CoV-2 after natural infection: a prospective observational cohort in 13 care homes in England;Jeffery-Smith;Lancet. Healthy Longev.,2021

3. Kinetics of the severe acute respiratory syndrome coronavirus 2 antibody response and serological estimation of time since infection;Pelleau;J. Infect. Dis.,2021

4. Monitoring the proportion of the population infected by SARS-CoV-2 using age-stratified hospitalisation and serological data: a modelling study;Hozé;Lancet Public Health,2021

5. En mai 2020, 4,5 % de la population en France métropolitaine a développé des anticorps contre le SARS-CoV-2. Etudes et Résultats;Warszawski;Direction de la Recherche, des études, de l’évaluation et des statistiques,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differences in SARS-CoV-2 antibodies depending on age, blood group, and sex in a Swedish blood donor cohort;Scandinavian Journal of Clinical and Laboratory Investigation;2024-06-21